Scientific Programme

All sessions will be recorded and available on demand for the registered participants after the end of the summit.
Please note that the below programme is scheduled in Central European Times (CET).
If you wish to convert time into your country’s time zone please click HERE
to download the Scientific Programme of the Summit in PDF file

Thursday 18th March
 Time CET
13:00 – 13:10 Welcome
Prof. Sinthia Bosnic-Anticevich
13:10 – 14:40 COVID-19 session
Chair: Prof. Antonio Anzueto (United States)

COVID & Chronic Respiratory Disease: Risks and management
Prof. David Halpin (United Kingdom)

COVID-19 and the future (what we need to do, with and without a vaccine)
Prof. Tobias Welte (Germany)

14:40 – 15:00 Break
15:00 – 16:30 Environment and Lung Health
Chair: Prof. Joan B. Soriano (Spain)

Impact of Global warming and Climate Change
Prof. Josep M. Anto (Spain)

Inhalers and F-gas
Dr. Omar Usmani (United Kingdom)

Pro/ Con: E-cigarette: is this a valuable aid to smoking cessation?
Pro: Dr. Alan Kaplan (Canada)
Con: Prof. Antonio Anzueto (United States)

Current questions in asthma management

Supported by

Chair:Prof. Alberto Papi (Italy) & Prof. Giorgio Walter Canonica (Italy)

New biologics in severe asthma - how to choose?
Dr. Nick Hanania (United States)

Pro/ Con: Should SABAs be replaced as the reliever of choice?
Pro: Prof. Helen Reddel (Australia)
Con: Dr Dermot Ryan (United Kingdom)

Friday 19th March
13:00 – 14:30 COPD: Treatment controversies
Chair: Dr. Marc Miravitlles (Spain)

Pro/ Con: LABA/LAMA, should we start earlier?
Pro: Dr. Bartolome Celli (United States)
Con: Prof. Antonio Anzueto (United States)

Pro/ Con: Triple therapy, does it reduce mortality?
Pro: Dr. MeiLan Han (United States)
Con: Dr. Anthony D'urzo (Canada)
Child health – pediatric asthma
Chair: Prof. Steve Turner (United Kingdom) & Prof. Nikos Papadopoulos (Greece)

Pediatric asthma management during COVID – what changes?
Prof. Adnan Custovic (United Kingdom)

Asthma biomarkers in children
Prof. Sejal Saglani (United Kingdom)

Adults versus children: Differences between asthma guidelines and advice
Dr. James Paton (United Kingdom)

14:30 – 14:45 Break 
14:45 – 16:15

ISAR Session: Severe asthma in real-life - learnings from ISAR and beyond

Chair: Prof. David Price (United Kingdom)

ISAR updates
Dr. Anne-Frieda Taurel (Singapore)

Overview of ISAR recent publications
Prof. Giorgio Walter Canonica (Italy)

Ongoing research on Biolocs from ISAR
Prof. David Price (United Kingdom)

The role of exacerbations on lung function trajectory and early intervention with Biologics
Prof. Rupert Jones (United Kingdom)

Differences in asthma disease severity by socioeconomic status and ethnicity
Dr. John Busby (United Kingdom)

Approaches to identify hidden severe asthma within the COPD population - Panel discussion
Host: Prof. Chin Kook Rhee (South Korea)
Panelists: Prof. Arnaud Bourdin (France), Prof. Leif Bjermer (Sweden)
Speaker: Prof. David Price (United Kingdom)

The future of registry: embedding data collection in routine care - Panel discussion
Host: Prof. David Price (United Kingdom)
Panelists: Prof. Celeste Porsbjerg (Denmark), Prof. John Blakey (Australia) & Prof. Leif Bjermer (Sweden)

ILD/IPF Session

Supported by 

Chair: Dr. Mark Jones (United Kingdom)

Early identification of IPF - what new tools can help?
Dr. Pilar Rivera Ortega (United Kingdom)

Post-COVID fibrosis
Prof. Fernando Martinez (United States)

Saturday 20th March
13:00 – 14:30 Digital Health
Chair: Prof. Henry Chrystyn (United Kingdom)

The evidence for digital inhalers
Prof. John Blakey (Australia)

HE aspects of digital technologies
Assoc. Prof. Job van Boven (Netherlands)

14:30 – 14:45 Break  
14:45 – 15:45 Thresholds for referral
Chair: Prof. Mike Thomas (United Kingdom)

Dr. Alan Kaplan (Canada)

Prof. Ted Popov (Bulgaria)

Prof. Chin Kook Rhee (South Korea)

15:45-16:00 Closing remarks
Prof. Sinthia Bosnic-Anticevich